Article By:
InvestInMJ
Monday, January 30, 2017 3:00 PM EDT
We recently had the pleasure to speak to Robert Brooke, the CEO of Vitality Biopharma, a publicly traded pharmaceutical company focused on cannabis based medical drugs, and their recent R&D breakthrough for those suffering from IBD & Crohn's Disease.